Stefan Braam, CEO Ncardia, presenting at Dutch Life Sciences Conference
With more than 450 life sciences companies the Dutch Life Sciences sector has doubled in size during the last decades. The Dutch Life Sciences Conference is the foremost life sciences business network event in the Netherlands.
The fast-emerging field of platform technologies like organ-on-a-chip will improve the drug development trajectory with great impact for patients and society. Companies developing and offering these technologies are challenging the pharmaceutical industry to radical change the way new therapies are being developed. In this session different platforms will be presented, their applied business models and how these platform companies collaborate with the pharmaceutical industry.
Stefan Braam, CEO Ncardia, is delighted to attend and present as part of the "Next generation platform technologies in drug discovery and validation" afternoon session.
Session: "Next generation platform technologies in drug discovery and validation"
Date and time: November 29, 13:30 - 14:45
Location: CORPUS Congress Centre,
Leiden Bio Science Park (Oegstgeest area) - the Netherlands